These substances, which include pharmaceutical products and biomarkers, have a broad range of applications. Biotechnology's intersection with pharmacology holds promise for developing innovative ...

The disciplines of pharmacology and physiology touch on virtually every field of the biomedical sciences, presenting endless opportunities to discover disease mechanisms and develop new treatments.

Pharmacology is a branch of biomedical science, encompassing clinical pharmacology, that is concerned with the effects of drugs/pharmaceuticals and other xenobiotics on living systems, as well as ...

Using an innovative and recently validated animal model of IBS, the researchers showed that opioid delta-receptor agonists can ameliorate stress-induced IBS symptoms by acting on the insular cortex of ...

A 51-year old man presents for removal of an epidermal cyst on his left lower eyelid. Two lesions are seen on his right arm; no history can be provided. What's the diagnosis?

Genomic distances between the miRNA coding regions are 2.5, 9, and 3.6 kb, respectively. Figure 3. An overview of the roles of miR-133 in cardiac remodeling as well as some endogenous and exogenous ...

The flavonoid silymarin and one of its structural components, silibinin, are substances with documented hepatoprotective properties. Their mechanisms of action are still poorly understood. However ...

Trusted resource of information on Emergency Medicine that includes news, articles, medical conditions, medications, ...

A research team led by Professor Kazuaki Sawada and Project Assistant Professor Hideo Doi of the Department of Electrical and Electronic Information Engineering, Toyohashi University of Technology has ...

February 10-11: BIO CEO & Investor Conference 2025. Daniel Vitt, Ph.D., Chief Executive Officer of Immunic, will participate in one-on-one meetings at this conference, taking place in New York.

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

retriever generates disease-specific transcriptional drug response signatures by merging transcriptional signatures over time, concentration, and cell-type. These signatures can then be matched to ...